43results about How to "Less frequent seizures" patented technology

The present invention relates to traditional Chinese medicine for treating coronary heart disease and stenocardia is made from (by wt.%) salvia root 50-97%, notoginseng 2-48% and borneol 0.2-3%, in which the salvia root and notoginseng and hot extracted with water, then filtering, concentrating, alcohol precipitating, standing still, recovering ethyl alcohol, concentrating, into extractum, further blended with borneol and adjuvant polyglycol-6000 to form into product.

The invention provides an orally administered traditional Chinese medicine formula for treating epilepsy. The traditional Chinese medicine formula comprises the following components in parts by weight: 9-15 parts of codonopsis, 9-15 parts of prepared rehmannia root, 12-18 parts of yam, 9-15 parts of eucommia, 9-15 parts of wolfberry fruit, 7-11 parts of dogwood, 7-11 parts of angelica, 4-8 parts of licorice, 9-15 parts of grass-leaved sweetflag, 4-8 parts of polygala, 9-15 parts of rhizoma gastrodiae and 12-18 parts of uncaria. Compared with the prior art, the traditional Chinese medicine can treat epilepsy according to the internal causes on the basis of the syndrome difference, has the advantages of rapid acting, low cost, no toxic or side effect and obvious effect, and can treat both the principal and secondary aspects of the disease.

The invention discloses a hang-over solid beverage containing glutamine and a preparation method thereof. The hangover solid beverage is mainly prepared from the following components in parts by weight: 20-30 parts of glutamine, 15-25 parts of alanine, 5-10 parts of methionine, 10-20 parts of ganoderan, 10-20 parts of coriolus versicolor polysaccharide, 10-15 parts of watermelon powder, 0.1-0.8 part of lecithin, 2-5 parts of VC (vitamin C), 2-5 parts of maltitol, 0.05-0.15 part of citric acid, and 1-3 parts of beta-cyclodextrin. The solid beverage has the effects of removing hang-over, protecting stomach and liver, promoting urination and improving immunity, tastes sour and sweet, safe to eat, concise, convenient to carry and long in preservation period and has a wide application range.

The invention provides an oral Chinese patent medicine for treating epilepsy. The oral Chinese patent medicine comprises the following components in part by weight: 28 to 32 parts of bamboo juice, 7 to 11 parts of pinellia ternate, 9 to 15 parts of acorus gramineus, 9 to 15 parts of arisaema cum bile, 7 to 11 parts of bulbus fritillariae, 9 to 15 parts of gastrodia elata, 9 to 15 parts of uncaria, 1 to 3 parts of scorpion, 9 to 15 parts of white-stiff silkworm, 4 to 8 parts of roasted thinleaf milkwort rootbark, 28 to 32 parts of dens draconis, and 7 to 11 parts of scarlet fushen. Compared with the prior art, the Chinese patent medicine treats epilepsy by differentiation of symptoms and signs aiming at the internal pathogenic factors of epilepsy, has quick response, and an obvious effect, is low in cost, does not have toxic or side effect and can address both the symptoms and root causes.

The invention provides traditional Chinese medicine used for treating tinnitus. The traditional Chinese medicine is composed of tibet lyonia leaves, spina date seeds, rhizoma acori graminei, nacre mothers of pearls, dragon bone, woodblock stone, rust-coloured crotalaria herbs with roots, deer-horn glue, polygala tenuifolia, black sesame, self heal, radix rehmanniae preparata and liquorice. The traditional Chinese medicine can be clinically used for treating tinnitus.

The invention provides a musk Baoxin long-acting medicine product, which comprises a musk Baoxin quick-release tablet and a gastric floating type musk Baoxin pulse release tablet. According to the musk Baoxin long-acting medicine product disclosed by the invention, the quick-acting characteristic of the original preparation is kept while the medicine taking times is reduced. More importantly, the internal behavior of the original preparation is not changed. The musk Baoxin long-acting medicine product has a positive meaning for enriching the dose type of the musk Baoxin preparation and satisfying the clinic requirement application.

The invention discloses a medicine used for treating epilepsy, which belongs to a field of traditional Chinese medicine.The medicine is prepared by certain weight of common aucklandia root, dried green orange peel, dried tangerine peel, zedoray rhizome, tuber of dwarf lilyturf, chrysanthemum flower, thinleaf milkwort root, coptis rhizome, Chinese corktree, rhubarb root and parched cyperus tuber. Putting the material medicine into a marmite and adding water for proper soaking: first, using furious fire to boil, then using small fire to heat for half an hour. The liquid medicine is filtered, and proper water is added into the decoction medicine and heated for half an hour, and then the medicine liquid is filtered again. The twice liquid medicine is mixed together and is cooled. The medicine is respectively served half an hour before breakfast and two hours after supper.The treating principle of the traditional Chinese medicinal prescription used for treating the epilepsy is mainly to clear heat and promote diuresis, regulate qi-flowing for eliminating phlegm, condition kidney and spleen as well as invigorate heart and spleen, and organically combine with elimination of the evil and support of the healthy energy, treating both manifestation and root cause of disease and balancing yin and yang.Thereby allowing the sufferers to recover physical fitness as soon as possible and enhance disease resistance on a premise of not interrupting treatment and healing.

The invention discloses frankincense-myrrh compound volatile oil and its preparation method and use. The preparation method of the frankincense-myrrh compound volatile oil comprises that crude frankincense and crude myrrh are mixed according to a weight ratio of (1: 50) to (50: 1) and the frankincense-myrrh compound volatile oil is extracted from the mixture. The frankincense-myrrh compound volatile oil can be extracted by a steam distillation technology, an organic solvent immersion extraction technology or a supercritical extraction technology. A result of an experiment shows that the frankincense-myrrh compound volatile oil has good effects of resisting isoprenaline-caused rat myocardial ischemia, protecting cardiocytes cultured in vitro from anoxia/reoxygenation, relieving angina and reducing angina attack frequency or reducing a pain degree in an angina attack, has treatment effects which are obviously better than treatment effects of crude frankincense-myrrh powder and a frankincense-myrrh water decoction, can be utilized for preparation of medicinal preparations for treating myocardial ischemia and/or angina, and especially can be utilized for preparation of a medicinal preparation for treating heart blood stasis-caused angina.

The invention provides an oral Chinese medicinal preparation for treating epilepsy. The oral Chinese medicinal preparation for treating epilepsy comprises the following components in part by weight: 9 to 15 parts of gastrodia elata, 9 to 15 parts of uncaria rhynchophylla, 9 to 15 parts of geosaurus, 9 to 15 parts of root of rehmannia, 9 to 15 parts of acorus gramineus, 7 to 11 parts of gardenia, 7 to 11 parts of pinellia ternate, 7 to 11 parts of arisaema cum bile, 4 to 8 parts of felwort, 3 to 7 parts of akebia stem, and 1 to 3 parts of scorpion. Compared with the prior art, the Chinese medicinal preparation treats epilepsy by differentiation of symptoms and signs aiming at the internal pathogenic factors of epilepsy, has quick response and an obvious effect, is low in cost, does not have toxic or side effect, and can address both the symptoms and root causes.

A Chinese medicine for treating the acute or chronic myocardial ischemia diseases is prepared from 4 Chinese-medicinal materials: notoginseng, Chuan-xiong rhizome, dalbergia wood and valeriana officinalis. Its advantages are quickly taking its high curative effect (2-3 min), low dosage and no toxic by-effect.

The invention provides an oral Chinese medicinal composition for treating senile dementia. The Chinese medicinal composition for treating senile dementia comprises the following components in part by weight: 7 to 11 parts of peach kernel, 7 to 11 parts of safflower, 9 to 15 parts of red paeony root, 9 to 15 parts of ligusticum wallichii, 9 to 15 parts of acorus gramineus, 7 to 11 parts of zedoary, 4 to 8 parts of welsh onion, 4 to 8 parts of ginger and 9 to 15 parts of geosaurus. Compared with the prior art, the oral Chinese medicinal composition can treat senile dementia by differentiation of symptoms and signs aiming at the internal pathogenic factors of senile dementia, has quick response, and an obvious effect, is low in cost, does not have toxic or side effect and can address both the symptoms and root causes.

The invention discloses a traditional Chinese medicine formula for treating an aged coronary heart disease, and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 20 parts of herba cistanche, 18 parts of radix rehmanniae praeparata, 12 parts of fruit of Chinese wolfberry, 20 parts of astragalus membranaceus, 15 parts of codonopsis pilosula, 12 parts of radix ophiopogonis, 9 parts of schisandra chinensis, 12 parts of salviae miltiorrhizae, 15 parts of angelica sinensis, 12 parts of ligusticum wallichii, 12 parts of fructus trichosanthis, 8 parts of poria cocos, 10 parts of bighead atractylodes rhizome, 6 parts of liquorice and 4 parts of pseudo-ginseng. The traditional Chinese medicine has the beneficial effects that natural traditional Chinese medicines are adopted as raw materials, so that the traditional Chinese medicine is applied to recuperative medical care of the aged coronary heart disease by tonifying the kidneys and tonifying qi, and is accurate in curative effect, and free of a toxic or side effect; the aged coronary heart disease can be effectively cured and does not easily recur; and the total effective rate reaches 98%.

The invention belongs to the traditional Chinese medicine field, and more specifically to a traditional Chinese medicine preparation for treating angina pectoris and a preparation method thereof, which is characterized in that the traditional Chinese medicine preparation for treating angina pectoris is prepared from the following traditional Chinese medicine raw materials including, by weight, 10-15 parts of ramulus cinnamomi, 10-15 parts of radix et rhizoma asari, 15-20 parts of radix et rhizoma salviae miltiorrhizae, 10-15 parts of pseudo-ginseng, 2-3 parts of frankincense, 5-10 parts of rhizoma chuanxiong, 10-15 parts of Radix Astragali, 5-10 parts of faeces trogopterori, 5-10 parts of rhizoma corydalis, 3-5 parts of pollen typhae, 3-5 parts of radix angelicae sinensis, 2-3 parts of cyperus rotunus, 2-3 parts of radix arnebiae, 5-8 parts of caulis spatholobi, and 3-5 parts of flos carthami. The traditional Chinese medicine preparation for treating angina pectoris and the preparation method thereof have the advantages that the used traditional Chinese medicines accord with regulations of Pharmacopoeia of the People's Republic of China, and the medicines are safe and reliable. The medicines accord with each other in properties, have the efficacy of activating blood circulation to dissipate blood stasis, promoting the immune system and strengthening the body homeostasis, inducing astringency, stopping bleeding and relieving pain, and has the characteristics of definite therapeutic effect, fast effectiveness, high cure rate and no side-effect in the treatment of the angina pectoris.

The invention relates to a Cremastrae Pseudobulbus composition and a preparation method and application thereof. The composition consists of the following raw materials (by weight): 80-120 parts of Cremastrae Pseudobulbus extract, 10-20 parts of ocean fish enzymatic hydrolysate, 10-30 parts of green papaya extract, 5-15 parts of lumbricus extract, 5-15 parts of monkshood extract, 10-20 parts of angelica keiskei extract, 5-15 parts of Lactobacillus curvatus, and 50-70 parts of maltodextrin. The invention provides a compound Cremastrae Pseudobulbus and ocean fish peptide composition with relatively simple composition, clear effective components, functions proved by animal experiments and no side effects, and the composition can significantly reduce uric acid and relieve gout.

The invention provides a traditional Chinese medicine for treating angioneurotic headache. The traditional Chinese medicine includes the following components by weight: 25-35 parts of gypsum, 2-6 parts of asarum, 3-7 parts of scorpion (processed), 8-12 parts of white muscardine silkworm, 4-8 parts of raw rhizoma typhon, 12-18 parts of abalone shell, 2-6 parts of processed Rhizoma Arisaematis, 8-12 parts of safflower, 6-12 parts of rhizoma Gastrodiae, 2-4 parts of licorice and 3-7 parts of Ligusticum wallichii. The traditional Chinese medicine for treating angioneurotic headache provided by the invention has the advanategs of good effect, quick effectiveness, no side effect, low recurrence rate and simultaneous treatment of principal and subordinate symptoms, and effectively relieves the pain of patients.

The invention relates to medicinefor treating cardiac neurosis. The medicine is prepared from, by weight, 6 parts of fructus aurantii, 11 parts of prepared rehmannia roots, 8 parts of fructus gardeniae preparatus, 15 parts of tuber fleeceflower stems, 12 parts of danshen roots, 8 parts of rhizoma corydalis, 9 parts of Chinese dodder seeds and 7 parts of radix polygalae. According to the medicine,the fructus aurantii is used for regulating qi, dredging internal energy, removing stasis and dissipating swelling; the prepared rehmannia roots are used for nourishing yin, supplementing blood, boosting essence and replenishing the marrow; the fructus gardeniae preparatus is used for cooling blood for hemostasis; the tuber fleeceflower stems are used for tranquillizing mind by nourishing the heart, dredging collaterals and dispelling wind; the danshen roots are used for removing stasis, relieving pain, activating blood to promote menstruation, clearing away heart-fire and relieving restlessness; the rhizoma corydalis is used for invigorating blood circulation, tonifying qi and relieving pain; the Chinese dodder seeds are used for nourishing the liver and kidney, securing essence, arresting polyuria, improving eyesight and checking diarrhea; the radix polygalae is used for calming nerves, developing intelligence, eliminating phlegm and removing swelling. All the medicinal materials arecombined to be used and jointly achieve the effects of promoting qi and blood circulation, tonifying the kidney, receiving yang and tranquillizing mind by nourishing the heart. Clinical experiments indicate that by means of the medicine, cardiac neurosis can be treated safely and effectively.

The invention relates to a medicine for treating epilepsy. The medicine is prepared from the following medicinal raw materials in parts by weight: 2 parts of rhizoma arisaematis, 3 parts of pinellia ternata, 3 parts of scutellaria baicalensis, 2 parts of rhizoma acori graminei, 3 parts of radix bupleuri, 4 parts of cassia twig, 3 parts of fructus aurantii immaturus, 2 parts of bamboo shaving and 2 parts of uncaria rhynchophylla. According to the medicine, rhizoma arisaematis has the effects of drying dampness, eliminating phlegm, dispelling wind and convulsion; pinellia ternata has the effects of drying dampness, eliminating phlegm, calming adverse-rising energy and relieving vomiting; scutellaria baicalensis has the effects of clearing heat, drying dampness and purging fire for removing toxin; rhizoma acori graminei has the effects of inducing resuscitation, eliminating phlegm, refreshing and reinforcing intelligence; radix bupleuri has the effects of soothing liver and promoting spleen yang; cassia twig has the effects of reinforcing yang to generate qi; fructus aurantii immaturus has the effects of eliminating phlegm and dissipating masses; bamboo shaving has the effects of clearing heat and eliminating phlegm; and uncaria rhynchophylla has the effects of calming endogenous wind and arresting convulsion. The medicinal materials are combined to achieve the effects of eliminating phlegm, dispelling wind, inducing resuscitation and calming epilepsy, and can be used for effectively treating epilepsy. Clinical experiments prove that the medicine can be used for safely and effectively treating epilepsy.

The invention provides a Chinese patent medicine for treating angioneurotic headache, which comprises the following ingredients by weight part: 12-18 parts of Ligusticum wallichii, 28-32 parts of uncaria rhynchophylla, 28-32 parts of abalone shell, 28-32 parts of white peony root, 8-12 parts of scorpion and 8-12 parts of licorice. Compared with the prior art, the Chinese patent medicine for treating angioneurotic headache has the advantages of good effect, fast curative effect, no side-effect and low recurrence rate. The Chinese patent medicine treats both principal and secondary aspect of disease and effectively releases the illness of the patient.

A traditional Chinese medicine for treating kidney-essence deficiency caused tinnitus is made from stem or leaf of fortune Euonymus, fennelfower seed, dogwood, hiraute shiny bugleweed herb, carrageen, Chinese yam, all-grass of climbing violet, tuber of five-leafed yam, desertliving Cistanche and sheep kidney. The traditional Chinese medicine is clinically used for treating kidney-essence deficiency caused tinnitus.